Pfizer Inc (PFE)
40.80
+0.42 (+1.04%)
USD |
NYSE |
Mar 31, 16:00
40.75
-0.05 (-0.12%)
After-Hours: 20:00
Pfizer Price to Book Value: 2.397 for March 31, 2023
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 31, 2023 | 2.397 |
| March 30, 2023 | 2.372 |
| March 29, 2023 | 2.364 |
| March 28, 2023 | 2.349 |
| March 27, 2023 | 2.362 |
| March 24, 2023 | 2.372 |
| March 23, 2023 | 2.360 |
| March 22, 2023 | 2.350 |
| March 21, 2023 | 2.388 |
| March 20, 2023 | 2.397 |
| March 17, 2023 | 2.356 |
| March 16, 2023 | 2.371 |
| March 15, 2023 | 2.366 |
| March 14, 2023 | 2.344 |
| March 13, 2023 | 2.341 |
| March 10, 2023 | 2.314 |
| March 09, 2023 | 2.318 |
| March 08, 2023 | 2.357 |
| March 07, 2023 | 2.370 |
| March 06, 2023 | 2.415 |
| March 03, 2023 | 2.417 |
| March 02, 2023 | 2.386 |
| March 01, 2023 | 2.360 |
| February 28, 2023 | 2.383 |
| February 27, 2023 | 2.395 |
| Date | Value |
|---|---|
| February 24, 2023 | 2.452 |
| February 23, 2023 | 2.485 |
| February 22, 2023 | 2.489 |
| February 21, 2023 | 2.508 |
| February 17, 2023 | 2.537 |
| February 16, 2023 | 2.522 |
| February 15, 2023 | 2.543 |
| February 14, 2023 | 2.567 |
| February 13, 2023 | 2.582 |
| February 10, 2023 | 2.576 |
| February 09, 2023 | 2.544 |
| February 08, 2023 | 2.582 |
| February 07, 2023 | 2.559 |
| February 06, 2023 | 2.569 |
| February 03, 2023 | 2.587 |
| February 02, 2023 | 2.603 |
| February 01, 2023 | 2.581 |
| January 31, 2023 | 2.592 |
| January 30, 2023 | 2.557 |
| January 27, 2023 | 2.571 |
| January 26, 2023 | 2.598 |
| January 25, 2023 | 2.646 |
| January 24, 2023 | 2.625 |
| January 23, 2023 | 2.641 |
| January 20, 2023 | 2.648 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.314
Minimum
Mar 10 2023
4.542
Maximum
Dec 16 2021
3.227
Average
3.178
Median
Price to Book Value Benchmarks
| Moderna Inc | 3.097 |
| Amgen Inc | 35.27 |
| Gilead Sciences Inc | 4.872 |
| Johnson & Johnson | 5.256 |
| Eli Lilly and Co | 30.71 |
Price to Book Value Related Metrics
| PE Ratio | 7.445 |
| PS Ratio | 2.331 |
| PEG Ratio | 0.1759 |
| Price to Free Cash Flow | 8.986 |
| Price | 40.80 |
| Earnings Yield | 13.43% |
| Market Cap | 229.26B |
| PEGY Ratio | 0.1609 |
| Operating PE Ratio | 6.276 |
| Normalized PE Ratio | 6.660 |